TRC150094 attenuates progression of nontraditional cardiovascular risk factors associated with obesity and type 2 diabetes in obese ZSF1 rats
Shitalkumar P Zambad1, Siralee Munshi2, Amita Dubey3, Ram Gupta1, Rosa Anna Busiello4, Antonia Lanni5, Fernando Goglia6, Ramesh C Gupta7, Vijay Chauthaiwale8, Chaitanya Dutt91Pharmacology, 2Cellular and Molecular Biology, 3Pre-clinical and Safety Evaluation, Torrent Research Centre, Torrent Pharmace...
Main Authors: | Shitalkumar P Zambad, Siralee Munshi, Amita Dubey, et al |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2011-01-01
|
Series: | Diabetes, Metabolic Syndrome and Obesity |
Online Access: | http://www.dovepress.com/trc150094-attenuates-progression-of-nontraditional-cardiovascular-risk-a6002 |
Similar Items
-
Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction.
by: Isabel T N Nguyen, et al.
Published: (2020-01-01) -
A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats.
by: Pierre E Signore, et al.
Published: (2021-01-01) -
A small-molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase improves obesity, nephropathy and cardiomyopathy in obese ZSF1 rats
by: Pierre E. Signore, et al.
Published: (2021-01-01) -
TRC150094, a Novel Mitochondrial Modulator, Reduces Cardio-Metabolic Risk as an Add-On Treatment: a Phase-2, 24-Week, Multi-Center, Randomized, Double-Blind, Clinical Trial
by: Joshi D, et al.
Published: (2022-02-01) -
TRC210258, a novel TGR5 agonist, reduces glycemic and dyslipidemic cardiovascular risk in animal models of diabesity
by: Zambad SP, et al.
Published: (2013-12-01)